Clinical Trial

Medical Marijuana and Open Road Driving Task

Study acronym: ROADACE
Recruiting
View on ClinicalTrials.gov →
Summary
Medical marijuana use among adults 50 and older has more than doubled in the past decade with exponential increases projected in this demographic by 2050, and prescription opioids are one of the most common treatments for pain management in this population. To date, no studies systematically assess driving performance in a rigorous and ecologically valid manner accounting for long-term medical marijuana use and/or the combined effect of prescription opioid use in adults 50 and older who endorse chronic or severe non-malignant pain. Further, studies examining how older adults self-regulate prescription medication use and driving behavior is limited, with none rigorously examining medical marijuana.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-21.
Trial Details
NCT Number NCT06995937
Lead Sponsor Florida State University
Collaborators: University of Florida, National Institute on Drug Abuse (NIDA)
Conditions Medical Cannabis
Enrollment 250 participants
Start Date 2025-05-19
Primary Completion 2029-01-30 (estimated)
Study Completion 2029-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-20